Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Moldava Nad Bodvou – page 13

332 clinical trials in Moldava Nad Bodvou, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Moldava Nad Bodvou at a glance
332
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

332 trials in Moldava Nad Bodvou

Open in trial search

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Survodutide
  • Sponsor:Boehringer Ingelheim Espana S.A.

Sjogren's syndrome

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Major depression

Not recruiting

Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Seltorexant
  • Sponsor:Janssen Cilag International

Skin ulcer

Not recruiting

Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ALLO-APZ2-EB
  • Sponsor:Rheacell GmbH & Co. KG

Psoriatic arthropathy

Not recruiting

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Colitis ulcerative

Not recruiting

Study on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 3032950
  • Sponsor:Boehringer Ingelheim International GmbH

Migraine

Not recruiting

Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Lu Ag09222
  • Sponsor:H. Lundbeck A/S

Psoriatic arthropathy

Not recruiting

Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Hidradenitis

Not recruiting

Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Alvotech Swiss AG

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Moldava Nad Bodvou

What the registry says about research in the country

01 Cardiovascular Disease Management

Innovative research focusing on atherosclerotic cardiovascular disease and its treatment through novel therapeutic approaches. Studies are evaluating medications designed to reduce major adverse cardiovascular events.

  • Atherosclerotic Heart Disease
  • Cardiovascular Event Prevention
  • Lipid Management

These trials aim to improve outcomes for patients with established vascular disease and elevated cholesterol levels.

02 Blood Disorder Treatments

Comprehensive studies addressing hypertriglyceridemia and its various forms, including severe cases. Multiple trials are investigating new therapies to manage blood lipid levels effectively.

  • Triglyceride Level Management
  • Severe Hypertriglyceridemia
  • Long-term Safety Studies

Research focuses on developing innovative treatments to help patients achieve better control of their triglyceride levels.

03 Cardiac Health Innovation

Advanced research into chronic heart failure and atrial fibrillation, exploring new therapeutic options for better disease management and improved patient outcomes.

  • Heart Failure Treatment
  • Stroke Prevention
  • Blood Pressure Management

These studies aim to advance treatment options for various cardiac conditions, including resistant hypertension and post-heart attack care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.